Ozuriftamab vedotin

(Synonyms: BA3021; Anti-ROR2 ADC; CAB-ROR2-ADC)
Customer Review

Based on 1 Customer Validation

Ozuriftamab vedotin (BA3021), an antibody-drug conjugate (ADC), is a conditionally active biologic (CAB) anti-receptor tyrosine kinase orphan receptor 2 (ROR2) humanized monoclonal antibody Ozuriftamab (HY-145626) conjugated to VcMMAE (HY-15575). Ozuriftamab vedotin has antitumor activities.

For research use only. We do not sell to patients.

  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00